Systemic and Coronary Haemodynamics and Pharmacodynamics of Enalapril and Enalaprilat in Congestive Heart Failure
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 39 (4) , 29-40
- https://doi.org/10.2165/00003495-199000394-00007
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathyAmerican Heart Journal, 1988
- EnalaprilDrugs, 1986
- Pharmacokinetics and Pharmacodynamics of Enalapril in Patients with Congestive Heart Failure and Patients with HypertensionJournal of Cardiovascular Pharmacology, 1985
- Natriuretic Effect and Changes in Renal Haemodynamics Induced by Enalapril in Essential HypertensionDrugs, 1985
- Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).Hypertension, 1984
- Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.Circulation, 1984
- Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious ratsCanadian Journal of Physiology and Pharmacology, 1984
- Effect of the angiotensin I converting enzyme inhibitor, MK-421, on experimentally induced drinkingAppetite, 1982
- CaptoprilDrugs, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980